Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL) saw a significant decrease in short interest in July. As of July 31st, there was short interest totaling 15,664 shares, a decrease of 51.9% from the July 15th total of 32,559 shares. Based on an average trading volume of 7,540 shares, the days-to-cover ratio is presently 2.1 days. Approximately 1.0% of the company’s shares are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings cut Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, August 3rd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Basel Medical Group has an average rating of “Sell”.

Basel Medical Group Stock Performance

Shares of Basel Medical Group stock traded down $0.28 on Monday, hitting $4.98. The company had a trading volume of 2,955 shares, compared to its average volume of 27,083. The stock has a 50-day moving average of $6.40 and a 200-day moving average of $7.16. The company has a quick ratio of 1.83, a current ratio of 1.88 and a debt-to-equity ratio of 0.93. Basel Medical Group has a twelve month low of $4.17 and a twelve month high of $25.80.

Basel Medical Group (NASDAQ:BMGL) last posted its quarterly earnings data on Friday, June 26th. The company reported $0.01 EPS for the quarter. The company had revenue of $3.21 million during the quarter.

Institutional Trading of Basel Medical Group

A number of institutional investors have recently modified their holdings of the company. Marex Group plc bought a new position in shares of Basel Medical Group during the second quarter worth about $25,000. Virtu Financial LLC lifted its stake in Basel Medical Group by 108.8% in the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after acquiring an additional 17,608 shares in the last quarter. Finally, Citadel Advisors LLC bought a new stake in Basel Medical Group in the 3rd quarter valued at approximately $169,000.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.